Status:
UNKNOWN
Comorbid Esophageal Disorders in IBS Patients
Lead Sponsor:
Assiut University
Conditions:
GERD
Non-erosive Reflux Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
assess the incidence of the entire spectrum of esophageal disorders and possible theories for overlap in IBS patients using different diagnostic modalities.
Detailed Description
In the practice of a gastroenterologist, irritable bowel syndrome (IBS) is the most frequent functional disorder. Its prevalence in the population is 9.8%-12.8%. Its frequency in women is more than me...
Eligibility Criteria
Inclusion
- Established diagnosis of IBS (according to the Rome criteria of the III revision).
- Upper GIT symptoms in the form of heartburn (sometimes belching), a lump in the throat, and non-cardiac chest pain.
Exclusion
- History of thoracic, esophageal, or gastric surgery.
- Presence of duodenal or gastric ulcer on upper endoscopy.
- Presence of duodenal or gastric cancer on upper endoscopy.
- Conditions that prevent the installation of a nasogastric tube (nasopharyngeal formation, severe lumen-facial trauma).
- mental disorders state and disability.
- Pregnancy and breastfeeding.
Key Trial Info
Start Date :
February 25 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04759378
Start Date
February 25 2021
End Date
October 1 2021
Last Update
February 18 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.